TABLE G-1 Mean and Percentiles for Usual Intake of Thiamin (mg), CSFII, 1994–1995
|
| Percentile | |||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 0.69 | 0.11 | 0.22 | 0.29 | 0.45 | 0.63 | 0.87 | 1.15 | 1.35 | 1.70 |
SE | 0.05 | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.08 | 0.09 | 0.12 | |
7–11 mo | 45 | 0.90 | 0.38 | 0.53 | 0.61 | 0.75 | 0.9 | 1.05 | 1.19 | 1.27 | 1.42 |
SE | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | |
1–3 y | 702 | 1.14 | 0.53 | 0.68 | 0.76 | 0.91 | 1.1 | 1.32 | 1.55 | 1.71 | 2.04 |
SE | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | |
4–8 y | 666 | 1.44 | 0.75 | 0.92 | 1.01 | 1.19 | 1.4 | 1.65 | 1.91 | 2.09 | 2.49 |
SE | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | 0.06 | 0.09 | |
M 9–13 y | 180 | 1.933 | 0.82 | 1.06 | 1.21 | 1.49 | 1.86 | 2.30 | 2.74 | 3.04 | 3.66 |
SE | 0.07 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.08 | 0.11 | 0.13 | 0.19 | |
M 14–18 y | 191 | 2.17 | 0.89 | 1.16 | 1.33 | 1.65 | 2.08 | 2.60 | 3.14 | 3.50 | 4.28 |
SE | 0.09 | 0.06 | 0.09 | 0.10 | 0.09 | 0.09 | 0.15 | 0.17 | 0.20 | 0.59 | |
M 19–30 y | 328 | 2.03 | 0.92 | 1.16 | 1.3 | 1.58 | 1.95 | 2.39 | 2.84 | 3.14 | 3.78 |
SE | 0.06 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.07 | 0.09 | 0.10 | 0.15 | |
M 31–50 y | 627 | 2.02 | 0.87 | 1.12 | 1.28 | 1.55 | 1.92 | 2.37 | 2.88 | 3.25 | 4.12 |
SE | 0.06 | 0.04 | 0.03 | 0.03 | 0.04 | 0.05 | 0.08 | 0.13 | 0.17 | 0.30 | |
M 51–70 y | 490 | 1.74 | 0.75 | 0.96 | 1.09 | 1.34 | 1.67 | 2.06 | 2.48 | 2.76 | 3.35 |
SE | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.06 | 0.08 | 0.09 | 0.14 | |
M 71+ y | 237 | 1.70 | 0.77 | 0.97 | 1.10 | 1.33 | 1.64 | 2.00 | 2.37 | 2.62 | 3.14 |
SE | 0.07 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.09 | 0.12 | 0.15 | 0.22 | |
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
F 9–13 y | 200 | 1.55 | 0.78 | 0.97 | 1.08 | 1.28 | 1.52 | 1.79 | 2.05 | 2.21 | 2.54 |
SE |
| 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | 0.10 |
F 14–18 y | 169 | 1.43 | 0.55 | 0.75 | 0.87 | 1.09 | 1.37 | 1.70 | 2.07 | 2.33 | 2.93 |
SE |
| 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.08 | 0.11 | 0.14 | 0.23 |
F 19–30 y | 302 | 1.27 | 0.52 | 0.80 | 0.80 | 0.99 | 1.22 | 1.49 | 1.78 | 1.99 | 2.45 |
SE |
| 0.07 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.08 | 0.09 | 0.11 | 0.15 |
F 31–50 y | 590 | 1.34 | 0.51 | 0.71 | 0.82 | 1.03 | 1.28 | 1.59 | 1.92 | 2.15 | 2.67 |
SE |
| 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.06 | 0.07 | 0.12 |
F 51–70 y | 510 | 1.28 | 0.59 | 0.75 | 0.85 | 1.02 | 1.24 | 1.49 | 1.77 | 1.97 | 2.40 |
SE |
| 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.06 | 0.09 |
F 70+ y | 221 | 1.21 | 0.53 | 0.68 | 0.78 | 0.95 | 1.18 | 1.43 | 1.69 | 1.86 | 2.20 |
SE |
| 0.04 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 | 0.10 |
F pregnant | 33 | 1.53 | 0.67 | 0.87 | 0.98 | 1.2 | 1.48 | 1.81 | 2.14 | 2.36 | 2.82 |
SE |
| 0.39 | 0.47 | 0.42 | 0.42 | 0.39 | 0.38 | 0.40 | 0.46 | 0.51 | 0.65 |
F lactating | 16 | 2.35 | 0.88 | 1.17 | 1.35 | 1.71 | 2.21 | 2.83 | 3.52 | 3.99 | 5.03 |
SE |
| 0.52 | 0.64 | 0.58 | 0.55 | 0.50 | 0.48 | 0.55 | 0.73 | 0.89 | 1.31 |
All individuals | 5,527 | 1.59 | 0.58 | 0.79 | 0.91 | 1.16 | 1.49 | 1.90 | 2.37 | 2.71 | 3.50 |
SE |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.05 | 0.09 |
All indiv +P/L | 5,576 | 1.59 | 0.58 | 0.79 | 0.91 | 1.16 | 1.49 | 1.91 | 2.38 | 2.72 | 3.52 |
SE |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.05 | 0.10 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||
TABLE G-2 Mean and Percentiles for Usual Intake of Riboflavin (mg), CSFII, 1994–1995
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 0.97 | 0.18 | 0.34 | 0.44 | 0.65 | 0.93 | 1.25 | 1.56 | 1.77 | 2.18 |
SE |
| 0.07 | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.14 |
7–11 mo | 45 | 1.53 | 0.50 | 0.75 | 0.90 | 1.15 | 1.45 | 1.82 | 2.25 | 2.58 | 3.33 |
SE |
| 0.17 | 0.11 | 0.10 | 0.10 | 0.10 | 0.14 | 0.21 | 0.32 | 0.41 | 0.64 |
1–3 y | 702 | 1.66 | 0.73 | 0.96 | 1.10 | 1.33 | 1.62 | 1.94 | 2.27 | 2.50 | 2.98 |
SE |
| 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.07 |
4–8 y | 666 | 1.91 | 0.88 | 1.13 | 1.26 | 1.52 | 1.84 | 2.23 | 2.63 | 2.91 | 3.56 |
SE |
| 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | 0.09 | 0.16 |
M 9–13 y | 180 | 2.45 | 0.93 | 1.26 | 1.47 | 1.85 | 2.35 | 2.95 | 3.56 | 3.97 | 4.81 |
SE |
| 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.09 | 0.11 | 0.16 | 0.20 | 0.32 |
M 14–18 y | 191 | 2.64 | 0.99 | 1.32 | 1.53 | 1.94 | 2.50 | 3.18 | 3.92 | 4.43 | 5.54 |
SE |
| 0.11 | 0.06 | 0.07 | 0.07 | 0.08 | 0.10 | 0.14 | 0.19 | 0.23 | 0.32 |
M 19–30 y | 328 | 2.46 | 1.03 | 1.32 | 1.50 | 1.86 | 2.33 | 2.92 | 3.56 | 4.00 | 4.96 |
SE |
| 0.10 | 0.05 | 0.06 | 0.07 | 0.08 | 0.10 | 0.12 | 0.16 | 0.19 | 0.27 |
M 31–50 y | 627 | 2.30 | 0.97 | 1.27 | 1.44 | 1.76 | 2.18 | 2.70 | 3.30 | 3.74 | 4.78 |
SE |
| 0.06 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.08 | 0.12 | 0.16 | 0.30 |
M 51–70 y | 490 | 2.04 | 0.85 | 1.09 | 1.24 | 1.54 | 1.94 | 2.44 | 2.98 | 3.35 | 4.18 |
SE |
| 0.06 | 0.05 | 0.04 | 0.05 | 0.05 | 0.07 | 0.10 | 0.11 | 0.15 | 0.39 |
M 71+ y | 237 | 2.05 | 0.83 | 1.09 | 1.26 | 1.56 | 1.97 | 2.45 | 2.96 | 3.30 | 4.02 |
SE |
| 0.09 | 0.06 | 0.06 | 0.06 | 0.06 | 0.08 | 0.11 | 0.16 | 0.19 | 0.29 |
F 9–13 y | 200 | 2.01 | 0.92 | 1.18 | 1.34 | 1.62 | 1.97 | 2.35 | 2.73 | 2.98 | 3.46 |
SE |
| 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | 0.09 | 0.11 | 0.13 | 0.17 |
F 14–18 y | 169 | 1.75 | 0.61 | 0.84 | 0.99 | 1.28 | 1.66 | 2.12 | 2.61 | 2.94 | 3.64 |
SE |
| 0.09 | 0.07 | 0.09 | 0.10 | 0.09 | 0.08 | 0.15 | 0.18 | 0.22 | 0.64 |
F 19–30 y | 302 | 1.56 | 0.57 | 0.80 | 0.93 | 1.18 | 1.49 | 1.85 | 2.26 | 2.55 | 3.22 |
SE |
| 0.10 | 0.05 | 0.06 | 0.07 | 0.08 | 0.10 | 0.12 | 0.15 | 0.18 | 0.28 |
F 31–50 y | 590 | 1.58 | 0.64 | 0.85 | 0.96 | 1.18 | 1.50 | 1.89 | 2.30 | 2.58 | 3.26 |
SE |
| 0.04 | 0.05 | 0.03 | 0.03 | 0.05 | 0.04 | 0.06 | 0.08 | 0.10 | 0.18 |
F 51–70 y | 510 | 1.54 | 0.66 | 0.85 | 0.97 | 1.18 | 1.47 | 1.81 | 2.20 | 2.49 | 3.16 |
SE |
| 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.08 | 0.11 | 0.20 |
F 70+ y | 221 | 1.47 | 0.63 | 0.83 | 0.94 | 1.14 | 1.40 | 1.72 | 2.08 | 2.34 | 2.95 |
SE |
| 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.09 | 0.13 | 0.26 |
F pregnant | 33 | 1.77 | 0.51 | 0.83 | 1.01 | 1.35 | 1.74 | 2.16 | 2.55 | 2.79 | 3.26 |
SE |
| 0.37 | 0.44 | 0.54 | 0.58 | 0.56 | 0.42 | 2.76 | 0.18 | 0.17 | 0.46 |
F lactating | 16 | 2.88 | 0.93 | 1.38 | 1.66 | 2.17 | 2.81 | 3.50 | 4.19 | 4.62 | 5.47 |
SE |
| 0.50 | 0.59 | 0.60 | 0.60 | 0.57 | 0.52 | 0.47 | 0.46 | 0.49 | 0.62 |
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
All individuals | 5,527 | 1.93 | 0.69 | 0.94 | 1.10 | 1.40 | 1.81 | 2.31 | 2.89 | 3.32 | 4.35 |
SE |
| 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.05 | 0.07 | 0.11 |
All indiv +P/L | 5,576 | 1.94 | 0.69 | 0.95 | 1.10 | 1.41 | 1.82 | 2.32 | 2.90 | 3.33 | 4.36 |
SE |
| 0.03 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 | 0.05 | 0.06 | 0.11 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||
TABLE G-3 Mean and Percentiles for Usual Intake of Niacin (mg), CSFII, 1994–1995
|
|
| Percentile | ||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 8.23 | 1.60 | 2.90 | 3.90 | 5.70 | 7.90 | 10.40 | 13.10 | 14.80 | 17.80 |
SE |
| 0.63 | 0.52 | 0.62 | 0.63 | 0.61 | 0.63 | 0.76 | 0.92 | 1.04 | 1.37 |
7–11 mo | 45 | 11.02 | 4.20 | 5.90 | 7.00 | 8.80 | 10.90 | 13.10 | 15.20 | 16.50 | 18.90 |
SE |
| 0.75 | 0.69 | 0.69 | 0.69 | 0.72 | 0.78 | 0.84 | 0.89 | 0.93 | 1.00 |
1–3 y | 702 | 13.45 | 5.40 | 7.30 | 8.40 | 10.40 | 13.00 | 15.90 | 19.10 | 21.20 | 25.90 |
SE |
| 0.30 | 0.26 | 0.27 | 0.28 | 0.29 | 0.31 | 0.35 | 0.42 | 0.50 | 0.75 |
4–8 y | 666 | 17.60 | 8.20 | 10.50 | 11.90 | 14.20 | 17.10 | 20.40 | 23.90 | 26.20 | 31.40 |
SE |
| 0.33 | 0.51 | 0.33 | 0.34 | 0.41 | 0.31 | 0.51 | 0.61 | 0.69 | 1.15 |
M 9–13 y | 180 | 23.71 | 10.60 | 13.60 | 15.40 | 18.70 | 23.00 | 27.90 | 33.00 | 36.30 | 43.10 |
SE |
| 0.81 | 1.06 | 1.05 | 1.04 | 0.95 | 0.83 | 0.86 | 1.01 | 1.13 | 1.70 |
M 14–18 y | 191 | 28.90 | 12.00 | 15.90 | 18.20 | 22.30 | 27.60 | 34.00 | 41.20 | 46.50 | 58.80 |
SE |
| 1.28 | 1.08 | 1.10 | 1.10 | 1.12 | 1.25 | 1.55 | 1.99 | 2.34 | 3.32 |
M 19–30 y | 328 | 31.83 | 13.80 | 17.60 | 19.90 | 24.50 | 30.50 | 37.70 | 45.40 | 50.60 | 61.60 |
SE |
| 1.29 | 0.80 | 0.85 | 0.90 | 1.04 | 1.26 | 1.56 | 1.95 | 2.28 | 3.14 |
M 31–50 y | 627 | 29.39 | 13.80 | 17.50 | 19.60 | 23.40 | 28.30 | 34.10 | 40.50 | 45.10 | 55.30 |
SE |
| 0.78 | 0.53 | 0.53 | 0.53 | 0.55 | 0.66 | 0.96 | 1.45 | 1.88 | 3.03 |
M 51–70 y | 490 | 25.84 | 11.00 | 14.30 | 16.30 | 20.00 | 24.80 | 30.50 | 36.70 | 41.10 | 50.80 |
SE |
| 0.87 | 0.51 | 0.53 | 0.55 | 0.63 | 0.80 | 1.08 | 1.49 | 1.83 | 2.80 |
M 71+ y | 237 | 22.50 | 9.80 | 12.60 | 14.20 | 17.50 | 21.70 | 26.60 | 31.80 | 35.30 | 42.70 |
SE |
| 0.84 | 0.49 | 0.53 | 0.56 | 0.63 | 0.77 | 1.06 | 1.54 | 1.95 | 3.00 |
F 9–13 y | 200 | 18.53 | 8.90 | 11.20 | 12.60 | 15.10 | 18.20 | 21.60 | 25.00 | 27.20 | 31.60 |
SE |
| 0.72 | 0.55 | 0.59 | 0.61 | 0.66 | 0.73 | 0.83 | 0.97 | 1.09 | 1.40 |
F 14–18 y | 169 | 18.97 | 7.20 | 9.80 | 11.40 | 14.30 | 18.10 | 22.50 | 27.60 | 31.20 | 39.60 |
SE |
| 1.05 | 0.76 | 0.80 | 0.82 | 0.84 | 0.93 | 1.25 | 1.83 | 2.34 | 3.76 |
F 19–30 y | 302 | 18.17 | 7.10 | 9.50 | 11.00 | 13.80 | 17.50 | 21.80 | 26.20 | 29.10 | 35.20 |
SE |
| 0.94 | 0.53 | 0.73 | 0.81 | 0.84 | 0.87 | 1.12 | 1.45 | 1.73 | 3.02 |
F 31–50 y | 590 | 19.30 | 8.40 | 10.90 | 12.40 | 15.10 | 18.60 | 22.70 | 27.00 | 30.00 | 36.40 |
SE |
| 0.55 | 0.57 | 0.51 | 0.44 | 0.47 | 0.61 | 0.66 | 0.89 | 1.07 | 1.43 |
F 51–70 y | 510 | 18.38 | 8.80 | 11.00 | 12.30 | 14.70 | 17.80 | 21.50 | 25.20 | 27.60 | 32.70 |
SE |
| 0.38 | 0.40 | 0.40 | 0.41 | 0.40 | 0.40 | 0.48 | 0.55 | 0.63 | 1.23 |
F 70+ y | 221 | 17.30 | 7.50 | 9.70 | 11.10 | 13.60 | 16.80 | 20.50 | 24.20 | 26.60 | 31.70 |
SE |
| 0.45 | 0.47 | 0.47 | 0.47 | 0.47 | 0.48 | 0.51 | 0.62 | 0.73 | 1.05 |
F pregnant | 33 | 19.53 | 8.60 | 11.20 | 12.80 | 15.60 | 19.10 | 23.00 | 26.80 | 29.30 | 34.30 |
SE |
| 6.97 | 6.74 | 8.28 | 8.97 | 9.31 | 7.86 | 5.30 | 3.95 | 3.81 | 4.60 |
F lactating | 16 | 27.38 | 11.60 | 15.30 | 17.60 | 21.70 | 26.80 | 32.40 | 38.00 | 41.60 | 48.70 |
SE |
| 4.09 | 3.76 | 3.98 | 4.08 | 4.21 | 4.27 | 4.33 | 4.65 | 5.10 | 6.63 |
|
|
| Percentile | ||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
All individuals | 5,527 | 22.23 | 7.50 | 10.50 | 12.30 | 15.90 | 20.80 | 26.90 | 33.90 | 38.90 | 50.90 |
SE |
| 0.28 | 0.20 | 0.29 | 0.29 | 0.18 | 0.37 | 0.37 | 0.76 | 0.93 | 1.39 |
All indiv +P/L | 5,576 | 22.24 | 7.50 | 10.50 | 12.30 | 15.90 | 20.80 | 26.90 | 33.90 | 38.90 | 50.80 |
SE |
| 0.27 | 0.19 | 0.33 | 0.33 | 0.18 | 0.40 | 0.36 | 0.76 | 0.91 | 1.34 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||
TABLE G-4 Mean and Percentiles for Usual Intake of Vitamin B6 (mg), CSFII, 1994–1995
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 0.41 | 0.09 | 0.16 | 0.20 | 0.29 | 0.40 | 0.52 | 0.62 | 0.69 | 0.84 |
SE |
| 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 | 0.07 | 0.10 | 0.15 |
7–11 mo | 45 | 0.77 | 0.34 | 0.45 | 0.51 | 0.62 | 0.76 | 0.90 | 1.04 | 1.13 | 1.30 |
SE |
| 0.07 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.08 | 0.09 | 0.11 | 0.14 |
1–3 y | 702 | 1.31 | 0.58 | 0.74 | 0.84 | 1.02 | 1.27 | 1.55 | 1.84 | 2.03 | 2.44 |
SE |
| 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 | 0.09 |
4–8 y | 666 | 1.53 | 0.68 | 0.88 | 1.00 | 1.21 | 1.48 | 1.80 | 2.13 | 2.36 | 2.85 |
SE |
| 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.06 | 0.08 | 0.19 |
M 9–13 y | 180 | 2.04 | 0.80 | 1.07 | 1.24 | 1.55 | 1.96 | 2.45 | 2.94 | 3.27 | 3.96 |
SE |
| 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 | 0.14 | 0.20 |
M 14–18 y | 191 | 2.26 | 0.86 | 1.15 | 1.32 | 1.66 | 2.12 | 2.69 | 3.37 | 3.86 | 5.02 |
SE |
| 0.11 | 0.07 | 0.07 | 0.08 | 0.08 | 0.10 | 0.16 | 0.22 | 0.25 | 0.41 |
M 19–30 y | 328 | 2.43 | 0.94 | 1.25 | 1.44 | 1.81 | 2.31 | 2.91 | 3.57 | 4.01 | 4.98 |
SE |
| 0.11 | 0.06 | 0.07 | 0.07 | 0.09 | 0.10 | 0.13 | 0.16 | 0.19 | 0.26 |
M 31–50 y | 627 | 2.26 | 0.90 | 1.19 | 1.37 | 1.70 | 2.13 | 2.68 | 3.31 | 3.77 | 4.86 |
SE |
| 0.07 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.08 | 0.13 | 0.18 | 0.32 |
M 51–70 y | 490 | 2.04 | 0.80 | 1.06 | 1.23 | 1.54 | 1.95 | 2.45 | 2.97 | 3.32 | 4.06 |
SE |
| 0.06 | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | 0.08 | 0.11 | 0.13 | 0.19 |
M 71+ y | 237 | 1.99 | 0.77 | 1.01 | 1.17 | 1.48 | 1.89 | 2.39 | 2.93 | 3.29 | 4.08 |
SE |
| 0.09 | 0.04 | 0.05 | 0.05 | 0.06 | 0.08 | 0.12 | 0.17 | 0.21 | 0.32 |
F 9–13 y | 200 | 1.58 | 0.67 | 0.88 | 1.00 | 1.24 | 1.54 | 1.88 | 2.22 | 2.44 | 2.90 |
SE |
| 0.07 | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 | 0.09 | 0.11 | 0.12 | 0.17 |
F 14–18 y | 169 | 1.50 | 0.54 | 0.75 | 0.87 | 1.10 | 1.41 | 1.80 | 2.25 | 2.57 | 3.31 |
SE |
| 0.10 | 0.09 | 0.05 | 0.07 | 0.12 | 0.09 | 0.17 | 0.23 | 0.26 | 0.40 |
F 19–30 y | 302 | 1.44 | 0.55 | 0.76 | 0.88 | 1.10 | 1.38 | 1.71 | 2.06 | 2.31 | 2.86 |
SE |
| 0.08 | 0.04 | 0.05 | 0.05 | 0.06 | 0.07 | 0.11 | 0.14 | 0.17 | 0.25 |
F 31–50 y | 590 | 1.52 | 0.57 | 0.78 | 0.91 | 1.15 | 1.43 | 1.81 | 2.20 | 2.47 | 3.07 |
SE |
| 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.06 | 0.08 | 0.12 |
F 51–70 y | 510 | 1.50 | 0.63 | 0.82 | 0.94 | 1.15 | 1.43 | 1.77 | 2.13 | 2.38 | 2.93 |
SE |
| 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.07 | 0.08 | 0.12 |
F 70+ y | 221 | 1.46 | 0.56 | 0.76 | 0.88 | 1.11 | 1.41 | 1.76 | 2.12 | 2.35 | 2.84 |
SE |
| 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.07 | 0.08 | 0.12 |
F pregnant | 33 | 1.61 | 0.58 | 0.81 | 0.95 | 1.22 | 1.56 | 1.95 | 2.34 | 2.59 | 3.11 |
SE |
| 0.42 | 0.35 | 0.39 | 0.41 | 0.43 | 0.44 | 0.44 | 0.44 | 0.45 | 0.50 |
F lactating | 16 | 2.56 | 0.98 | 1.29 | 1.49 | 1.88 | 2.41 | 3.08 | 3.81 | 4.31 | 5.41 |
SE |
| 0.45 | 0.40 | 0.44 | 0.46 | 0.48 | 0.49 | 0.49 | 0.51 | 0.56 | 0.81 |
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
All individuals | 5,527 | 1.79 | 0.59 | 0.82 | 0.97 | 1.26 | 1.66 | 2.17 | 2.74 | 3.16 | 4.14 |
SE |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | 0.11 |
All indiv +P/L | 5,576 | 1.79 | 0.59 | 0.82 | 0.97 | 0.13 | 1.67 | 2.17 | 2.75 | 3.17 | 4.15 |
SE |
| 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | 0.11 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||
TABLE G-5 Mean and Percentiles for Usual Intake of Folate (µg), CSFII, 1994–1995
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 80 | 16 | 29 | 38 | 56 | 78 | 101 | 122 | 137 | 167 |
SE |
| 6 | 6 | 7 | 7 | 7 | 6 | 8 | 9 | 10 | 13 |
7–11 mo | 45 | 129 | 51 | 69 | 79 | 99 | 125 | 154 | 183 | 202 | 241 |
SE |
| 12 | 9 | 8 | 8 | 8 | 11 | 16 | 22 | 27 | 42 |
1–3 y | 702 | 182 | 70 | 93 | 108 | 136 | 173 | 218 | 268 | 303 | 382 |
SE |
| 5 | 4 | 4 | 5 | 5 | 5 | 6 | 8 | 12 | 37 |
4–8 y | 666 | 232 | 95 | 124 | 141 | 176 | 221 | 276 | 335 | 375 | 461 |
SE |
| 6 | 3 | 3 | 3 | 4 | 5 | 8 | 11 | 14 | 22 |
M 9–13 y | 180 | 334 | 112 | 153 | 180 | 234 | 310 | 407 | 517 | 595 | 770 |
SE |
| 17 | 10 | 11 | 12 | 13 | 16 | 21 | 31 | 40 | 65 |
M 14–18 y | 191 | 321 | 100 | 140 | 165 | 217 | 293 | 392 | 512 | 600 | 811 |
SE |
| 19 | 7 | 8 | 9 | 12 | 18 | 26 | 35 | 44 | 77 |
M 19–30 y | 328 | 322 | 112 | 148 | 172 | 223 | 297 | 394 | 505 | 584 | 758 |
SE |
| 18 | 6 | 6 | 7 | 10 | 18 | 24 | 29 | 36 | 76 |
M 31–50 y | 627 | 309 | 106 | 143 | 167 | 214 | 281 | 372 | 484 | 569 | 783 |
SE |
| 11 | 5 | 5 | 6 | 7 | 9 | 14 | 22 | 30 | 57 |
M 51–70 y | 490 | 286 | 97 | 131 | 153 | 198 | 263 | 348 | 447 | 518 | 680 |
SE |
| 10 | 6 | 6 | 6 | 7 | 8 | 12 | 18 | 23 | 37 |
M 71+ y | 237 | 297 | 101 | 137 | 161 | 209 | 276 | 362 | 458 | 527 | 680 |
SE |
| 15 | 6 | 6 | 7 | 9 | 13 | 20 | 32 | 42 | 68 |
F 9–13 y | 200 | 254 | 90 | 123 | 143 | 184 | 240 | 308 | 383 | 435 | 547 |
SE |
| 13 | 8 | 9 | 9 | 11 | 13 | 16 | 21 | 26 | 41 |
F 14–18 y | 169 | 223 | 72 | 98 | 116 | 152 | 205 | 273 | 352 | 409 | 540 |
SE |
| 16 | 7 | 6 | 7 | 8 | 12 | 19 | 35 | 57 | 145 |
F 19–30 y | 302 | 214 | 71 | 100 | 118 | 153 | 200 | 259 | 326 | 374 | 488 |
SE |
| 14 | 6 | 6 | 7 | 9 | 12 | 18 | 25 | 31 | 45 |
F 31–50 y | 590 | 227 | 74 | 103 | 120 | 155 | 208 | 277 | 357 | 414 | 551 |
SE |
| 8 | 4 | 4 | 5 | 5 | 7 | 10 | 16 | 22 | 41 |
F 51–70 y | 510 | 224 | 83 | 111 | 129 | 163 | 211 | 270 | 335 | 379 | 476 |
SE |
| 8 | 5 | 5 | 5 | 6 | 7 | 9 | 12 | 15 | 22 |
F 70+y | 221 | 224 | 75 | 105 | 124 | 161 | 212 | 273 | 338 | 383 | 477 |
SE |
| 9 | 5 | 6 | 6 | 7 | 9 | 11 | 14 | 17 | 25 |
F pregnant | 33 | 241 | 114 | 140 | 156 | 188 | 230 | 282 | 338 | 377 | 462 |
SE |
| 29 | 16 | 15 | 15 | 17 | 23 | 37 | 57 | 73 | 113 |
F lactating | 16 | 461 | 160 | 215 | 251 | 324 | 428 | 561 | 713 | 822 | 1,068 |
SE |
| 102 | 41 | 51 | 57 | 72 | 95 | 128 | 172 | 206 | 294 |
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
All individuals | 5,527 | 259 | 80 | 111 | 131 | 173 | 235 | 317 | 414 | 486 | 663 |
SE |
| 4 | 2 | 2 | 2 | 3 | 3 | 5 | 9 | 12 | 24 |
All indiv +P/L | 5,576 | 259 | 80 | 111 | 131 | 174 | 236 | 318 | 415 | 488 | 667 |
SE |
| 4 | 2 | 2 | 2 | 2 | 3 | 5 | 9 | 12 | 23 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||
TABLE G-6 Mean and Percentiles for Usual Intake of Vitamin B12 (µg), CSFII, 1994–1995
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
0–6 mo | 69 | 1.37 | 0.36 | 0.60 | 0.76 | 1.03 | 1.34 | 1.67 | 2.00 | 2.22 | 2.68 |
SE |
| 0.11 | 0.10 | 0.12 | 0.12 | 0.12 | 0.11 | 0.12 | 0.17 | 0.21 | 0.31 |
7–11 mo | 45 | 4.53 | 0.80 | 1.30 | 1.70 | 2.40 | 3.60 | 5.50 | 8.40 | 11.00 | 18.10 |
SE |
| 2.27 | 0.16 | 0.21 | 0.29 | 0.62 | 1.36 | 2.82 | 5.25 | 7.50 | 14.10 |
1–3 y | 702 | 3.36 | 1.44 | 1.85 | 2.08 | 2.52 | 3.11 | 3.92 | 4.95 | 5.73 | 7.63 |
SE |
| 0.12 | 0.07 | 0.07 | 0.06 | 0.06 | 0.08 | 0.13 | 0.26 | 0.38 | 0.74 |
4–8 y | 666 | 3.83 | 1.57 | 2.04 | 2.33 | 2.88 | 3.62 | 4.54 | 5.58 | 6.34 | 8.09 |
SE |
| 0.14 | 0.09 | 0.10 | 0.10 | 0.11 | 0.13 | 0.17 | 0.26 | 0.34 | 0.59 |
M 9–13 y | 180 | 6.23 | 2.00 | 2.90 | 3.40 | 4.40 | 5.90 | 7.50 | 9.40 | 10.90 | 14.50 |
SE |
| 0.46 | 0.17 | 0.21 | 0.25 | 0.33 | 0.45 | 0.60 | 0.83 | 1.04 | 1.65 |
M 14–18 y | 191 | 5.67 | 2.30 | 3.00 | 3.50 | 4.30 | 5.40 | 6.70 | 8.20 | 9.30 | 11.80 |
SE |
| 0.25 | 0.18 | 0.20 | 0.21 | 0.22 | 0.24 | 0.31 | 0.43 | 0.55 | 0.86 |
M 19–30 y | 328 | 5.99 | 2.20 | 2.90 | 3.40 | 4.30 | 5.60 | 7.30 | 9.00 | 10.30 | 13.10 |
SE |
| 0.30 | 0.16 | 0.15 | 0.17 | 0.20 | 0.27 | 0.41 | 0.56 | 0.66 | 0.96 |
M 31–50 y | 627 | 6.30 | 2.10 | 2.80 | 3.30 | 4.20 | 5.60 | 7.60 | 10.20 | 12.20 | 17.40 |
SE |
| 0.50 | 0.15 | 0.16 | 0.17 | 0.22 | 0.40 | 0.68 | 1.06 | 1.43 | 2.71 |
M 51–70 y | 490 | 6.92 | 1.80 | 2.40 | 2.80 | 3.60 | 5.20 | 8.10 | 12.80 | 17.10 | 30.10 |
SE |
| 1.00 | 0.11 | 0.12 | 0.15 | 0.20 | 0.52 | 1.18 | 2.50 | 4.19 | 10.60 |
M 71+ y | 237 | 6.25 | 1.80 | 2.40 | 2.80 | 3.70 | 5.10 | 7.40 | 10.80 | 13.80 | 22.90 |
SE |
| 0.80 | 0.17 | 0.20 | 0.22 | 0.30 | 0.49 | 0.91 | 1.75 | 2.65 | 5.87 |
F 9–13 y | 200 | 4.07 | 1.72 | 2.25 | 2.57 | 3.16 | 3.92 | 4.82 | 5.77 | 6.42 | 7.82 |
SE |
| 0.21 | 0.14 | 0.16 | 0.17 | 0.19 | 0.22 | 0.25 | 0.28 | 0.31 | 0.40 |
F 14–18 y | 169 | 4.18 | 1.30 | 1.90 | 2.30 | 2.90 | 3.90 | 5.10 | 6.50 | 7.50 | 9.90 |
SE |
| 0.33 | 0.14 | 0.18 | 0.19 | 0.23 | 0.29 | 0.42 | 0.63 | 0.82 | 1.31 |
F 19–30 y | 302 | 3.68 | 1.19 | 1.67 | 1.98 | 2.60 | 3.45 | 4.51 | 5.68 | 6.47 | 8.21 |
SE |
| 0.32 | 0.13 | 0.19 | 0.21 | 0.25 | 0.29 | 0.35 | 0.47 | 0.60 | 1.11 |
F 31–50 y | 590 | 4.24 | 1.27 | 1.74 | 2.02 | 2.55 | 3.41 | 4.88 | 7.29 | 9.51 | 16.09 |
SE |
| 0.39 | 0.10 | 0.11 | 0.12 | 0.15 | 0.20 | 0.34 | 1.03 | 1.95 | 5.34 |
F 51–70 y | 510 | 4.91 | 1.40 | 1.80 | 2.10 | 2.80 | 3.90 | 5.80 | 8.70 | 11.30 | 18.90 |
SE |
| 0.65 | 0.09 | 0.09 | 0.11 | 0.24 | 0.56 | 0.92 | 1.48 | 2.21 | 5.38 |
F 70+ y | 221 | 4.61 | 1.09 | 1.49 | 1.75 | 2.33 | 3.32 | 5.09 | 8.28 | 11.63 | 24.24 |
SE |
| 0.84 | 0.08 | 0.10 | 0.10 | 0.12 | 0.27 | 0.71 | 1.89 | 3.47 | 11.00 |
F pregnant | 33 | 3.83 | 1.40 | 1.94 | 2.27 | 2.90 | 3.70 | 4.62 | 5.55 | 6.16 | 7.39 |
SE |
| 1.45 | 1.24 | 1.59 | 1.78 | 1.94 | 1.72 | 1.28 | 1.32 | 1.41 | 1.32 |
F lactating | 16 | 6.63 | 1.90 | 2.80 | 3.40 | 4.60 | 6.30 | 8.20 | 10.30 | 11.70 | 14.60 |
SE |
| 1.55 | 1.11 | 1.30 | 1.39 | 1.52 | 1.62 | 1.69 | 1.77 | 1.86 | 2.19 |
| Percentile | ||||||||||
Gender/Age Categorya | N | Mean | 1st | 5th | 10th | 25th | 50th | 75th | 90th | 95th | 99th |
All individuals | 5,527 | 5.03 | 1.30 | 1.90 | 2.30 | 3.00 | 4.10 | 5.90 | 8.50 | 11.10 | 19.00 |
SE |
| 0.16 | 0.04 | 0.04 | 0.04 | 0.05 | 0.09 | 0.16 | 0.37 | 0.68 | 2.01 |
All indiv +P/L | 5,576 | 5.04 | 1.30 | 1.90 | 2.30 | 3.00 | 4.10 | 5.90 | 8.60 | 11.10 | 19.00 |
SE |
| 0.16 | 0.04 | 0.04 | 0.05 | 0.06 | 0.09 | 0.16 | 0.37 | 0.66 | 1.97 |
a SE = standard error; All indiv +P/L = all individuals plus pregnant and lactating women. SOURCE: Unpublished data on the usual intake distributions for selected B vitamins, K.Dodd and A.Carriquiry, Iowa State University, 1997. Based on transformation of CSFII data using the method of Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. 1996. A semiparametric transformation approach to estimating usual daily intake distributions. J Am Stat Assoc 91:1440–1449. | |||||||||||